| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 1,556 | Sold Some | -26,600 | -94.47 % | $8,013 | $7,624 | $-389 | -4.85 % | $6,650 | | | | | | News Article | History of Amvescap Plc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | 24,706 | Sold Some | -70,216 | -73.97 % | $127,236 | $121,059 | $-6,177 | -4.85 % | $17,554 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Nabi Biopharmaceuticals |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 22,129 | Added More | 11,016 | 99.12 % | $113,964 | $108,432 | $-5,532 | -4.85 % | $-2,754 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Nabi Biopharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 41,679 | No Change | 0 | 0 % | $187,556 | $204,227 | $16,672 | 8.88 % | $0 | | | | | | News Article | History of American International Group Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Fuller And Thaler Asset Management Inc | Institution | 394,500 | Sold Some | -6,600 | -1.64 % | $1,775,250 | $1,933,050 | $157,800 | 8.88 % | $-2,640 | | | | | | News Article | History of Fuller And Thaler Asset Management Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ing Groep Nv | Institution | 26,420 | Added More | 4,270 | 19.27 % | $118,890 | $129,458 | $10,568 | 8.88 % | $1,708 | | | | | | News Article | History of Ing Groep Nv Ownership Of Nabi Biopharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Madison Square Investors Llc | No Data | 3,563 | Sold Some | -4,201 | -54.10 % | $16,034 | $17,459 | $1,425 | 8.88 % | $-1,680 | | | | | | News Article | History of Madison Square Investors Llc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | | Sold All | -207,549 | -100 % | | | | 8.88 % | $-83,020 | | | | | | News Article | History of Millennium Management Llc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 42,245 | New Holding | 42,245 | 100 % | $190,103 | $207,001 | $16,898 | 8.88 % | $16,898 | | | | | | News Article | History of Morgan Stanley Ownership Of Nabi Biopharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 667,124 | Added More | 60,176 | 9.91 % | $3,002,058 | $3,268,908 | $266,850 | 8.88 % | $24,070 | | | | | | News Article | History of Northern Trust Corp Ownership Of Nabi Biopharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | 1,400 | Sold Some | -79,952 | -98.27 % | $6,300 | $6,860 | $560 | 8.88 % | $-31,981 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | 139,347 | Sold Some | -125,746 | -47.43 % | $627,062 | $682,800 | $55,739 | 8.88 % | $-50,298 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Soros Fund Management Llc | Institution | 51,700 | Added More | 21,900 | 73.48 % | $232,650 | $253,330 | $20,680 | 8.88 % | $8,760 | | | | | | News Article | History of Soros Fund Management Llc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Third Point Llc | Institution | 6,890,000 | No Change | 0 | 0 % | $31,005,000 | $33,761,000 | $2,756,000 | 8.88 % | $0 | | | | | | News Article | History of Third Point Llc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Two Sigma Investments Llc | Institution | 29,900 | Added More | 3,198 | 11.97 % | $134,550 | $146,510 | $11,960 | 8.88 % | $1,279 | | | | | | News Article | History of Two Sigma Investments Llc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 300 | No Change | 0 | 0 % | $1,350 | $1,470 | $120 | 8.88 % | $0 | | | | | | News Article | History of Us Bancorp De Ownership Of Nabi Biopharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wexford Capital Llc | Institution | 14,300 | New Holding | 14,300 | 100 % | $64,350 | $70,070 | $5,720 | 8.88 % | $5,720 | | | | | | News Article | History of Wexford Capital Llc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 1,000 | No Change | 0 | 0 % | $3,560 | $4,900 | $1,340 | 37.64 % | $0 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 221,273 | Sold Some | -26,445 | -10.67 % | $787,732 | $1,084,238 | $296,506 | 37.64 % | $-35,436 | | | | | | News Article | History of Axa Ownership Of Nabi Biopharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 1,832 | Sold Some | -106,393 | -98.30 % | $6,522 | $8,977 | $2,455 | 37.64 % | $-142,567 | | | | | | News Article | History of Barclays Plc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Batterymarch Financial Management Inc | Institution | 102,322 | Sold Some | -3,757 | -3.54 % | $364,266 | $501,378 | $137,111 | 37.64 % | $-5,034 | | | | | | News Article | History of Batterymarch Financial Management Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | 18,155 | New Holding | 18,155 | 100 % | $64,632 | $88,960 | $24,328 | 37.64 % | $24,328 | | | | | | News Article | History of Bnp Paribas Arbitrage Sa Ownership Of Nabi Biopharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Falcon Investment Management Llc | Institution | 71,591 | New Holding | 71,591 | 100 % | $254,864 | $350,796 | $95,932 | 37.64 % | $95,932 | | | | | | News Article | History of Falcon Investment Management Llc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 142 | Sold Some | -39,112 | -99.63 % | $506 | $696 | $190 | 37.64 % | $-52,410 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of Nabi Biopharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 95,445 | No Change | 0 | 0 % | $339,784 | $467,681 | $127,896 | 37.64 % | $0 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 1,099,115 | Sold Some | -166,284 | -13.14 % | $3,912,849 | $5,385,664 | $1,472,814 | 37.64 % | $-222,821 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Knight Capital Group Inc | Institution | | Sold All | -24,508 | -100 % | | | | 37.64 % | $-32,841 | | | | | | News Article | History of Knight Capital Group Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 8,639 | New Holding | 8,639 | 100 % | $30,755 | $42,331 | $11,576 | 37.64 % | $11,576 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | 2,865,404 | Sold Some | -50,300 | -1.72 % | $10,200,838 | $14,040,480 | $3,839,641 | 37.64 % | $-67,402 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Nabi Biopharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sg Americas Securities Llc | Institution | 10,247 | Sold Some | -13,053 | -56.02 % | $36,479 | $50,210 | $13,731 | 37.64 % | $-17,491 | | | | | | News Article | History of Sg Americas Securities Llc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Spark Lp | Institution | | Sold All | -33,500 | -100 % | | | | 37.64 % | $-44,890 | | | | | | News Article | History of Spark Lp Ownership Of Nabi Biopharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 2,300,452 | Added More | 37,042 | 1.63 % | $8,189,609 | $11,272,215 | $3,082,606 | 37.64 % | $49,636 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 3,662,832 | Added More | 197,648 | 5.70 % | $12,417,000 | $17,947,877 | $5,530,876 | 44.54 % | $298,448 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Nabi Biopharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Chicago Equity Partners Llc | Institution | | Sold All | -58,425 | -100 % | | | | 44.54 % | $-88,222 | | | | | | News Article | History of Chicago Equity Partners Llc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 18,760 | New Holding | 18,760 | 100 % | $63,596 | $91,924 | $28,328 | 44.54 % | $28,328 | | | | | | News Article | History of Credit Suisse Ownership Of Nabi Biopharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Dellacamera Capital Management Llc | Institution | 3,244,227 | No Change | 0 | 0 % | $10,997,930 | $15,896,712 | $4,898,783 | 44.54 % | $0 | | | | | | News Article | History of Dellacamera Capital Management Llc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Gamco Investors Inc Et Al | Institution | 18,000 | No Change | 0 | 0 % | $61,020 | $88,200 | $27,180 | 44.54 % | $0 | | | | | | News Article | History of Gamco Investors Inc Et Al Ownership Of Nabi Biopharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Harvest Management Llc | Institution | 39,590 | No Change | 0 | 0 % | $134,210 | $193,991 | $59,781 | 44.54 % | $0 | | | | | | News Article | History of Harvest Management Llc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 26,420 | Added More | 4,270 | 19.27 % | $89,564 | $129,458 | $39,894 | 44.54 % | $6,448 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Nabi Biopharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Knott David M | Institution | 5,065,853 | No Change | 0 | 0 % | $17,173,242 | $24,822,680 | $7,649,438 | 44.54 % | $0 | | | | | | News Article | History of Knott David M Ownership Of Nabi Biopharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 7,500 | Sold Some | -8,850 | -54.12 % | $25,425 | $36,750 | $11,325 | 44.54 % | $-13,364 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 55,919 | Added More | 4,760 | 9.30 % | $189,565 | $274,003 | $84,438 | 44.54 % | $7,188 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Nabi Biopharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 1,805 | Added More | 111 | 6.55 % | $6,119 | $8,845 | $2,726 | 44.54 % | $168 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 2,281 | Added More | 907 | 66.01 % | $7,733 | $11,177 | $3,444 | 44.54 % | $1,370 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Russell Frank Co | Institution | | Sold All | -34,139 | -100 % | | | | 44.54 % | $-51,550 | | | | | | News Article | History of Russell Frank Co Ownership Of Nabi Biopharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | 39,115 | Added More | 22,801 | 139.76 % | $132,600 | $191,664 | $59,064 | 44.54 % | $34,430 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Nabi Biopharmaceuticals |
| 2009-11-10 | 2009-09-30 | 13F-HR | Clarivest Asset Management Llc | Institution | 100,044 | Sold Some | -530,473 | -84.13 % | $351,154 | $490,216 | $139,061 | 39.60 % | $-737,357 | | | | | | News Article | History of Clarivest Asset Management Llc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-10 | 2009-09-30 | 13F-HR | Comerica Bank | Institution | 10,172 | New Holding | 10,172 | 100 % | $35,704 | $49,843 | $14,139 | 39.60 % | $14,139 | | | | | | News Article | History of Comerica Bank Ownership Of Nabi Biopharmaceuticals |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 52,253 | Added More | 5,000 | 10.58 % | $183,408 | $256,040 | $72,632 | 39.60 % | $6,950 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Nabi Biopharmaceuticals |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 2,000 | No Change | 0 | 0 % | $7,020 | $9,800 | $2,780 | 39.60 % | $0 | | | | | | News Article | History of Ubs Ag Ownership Of Nabi Biopharmaceuticals |
| 2009-11-09 | 2009-09-30 | 13F-HR | Roark Rearden And Hamot Capital Management Llc | Institution | 1,610 | Added More | 1,126 | 232.64 % | $5,732 | $7,889 | $2,157 | 37.64 % | $1,509 | | | | | | News Article | History of Roark Rearden And Hamot Capital Management Llc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 46,680 | No Change | 0 | 0 % | $157,778 | $228,732 | $70,954 | 44.97 % | $0 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of Nabi Biopharmaceuticals |
| 2009-11-06 | 2009-09-30 | 13F-HR | Schwab Charles Investment Management Inc | Institution | 77,800 | Sold Some | -25,000 | -24.31 % | $262,964 | $381,220 | $118,256 | 44.97 % | $-38,000 | | | | | | News Article | History of Schwab Charles Investment Management Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 44,201 | No Change | 0 | 0 % | $149,399 | $216,585 | $67,186 | 44.97 % | $0 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 311,503 | Sold Some | -15,607 | -4.77 % | $1,052,880 | $1,526,365 | $473,485 | 44.97 % | $-23,723 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-06 | 2009-08-31 | N-CSR | Valic Co Ii - Small Cap Value Fund | Small-Cap Value | 28,700 | No Change | 0 | 0 % | $97,006 | $140,630 | $43,624 | 44.97 % | $0 | | | | | | News Article | History of Valic Co Ii - Small Cap Value Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-11-05 | 2009-09-30 | 13F-HR | Parametric Portfolio Associates | Institution | | Sold All | -25,748 | -100 % | | | | 44.11 % | $-38,622 | | | | | | News Article | History of Parametric Portfolio Associates Ownership Of Nabi Biopharmaceuticals |
| 2009-11-05 | 2009-09-30 | 13F-HR | Proshare Advisors Llc | Institution | 13,395 | Sold Some | -6,623 | -33.08 % | $45,543 | $65,636 | $20,093 | 44.11 % | $-9,935 | | | | | | News Article | History of Proshare Advisors Llc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-05 | 2009-08-31 | N-CSR | Claymore Exchange Traded Fund Trust - Sabrient Stealth | Specialty & Misc | | Sold All | -1,420 | -100 % | | | | 44.11 % | $-2,130 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust - Sabrient Stealth Ownership Of Nabi Biopharmaceuticals |
| 2009-11-04 | 2009-09-30 | 13F-HR | Geewax Plus Partners Llc | Institution | | Sold All | -5,000 | -100 % | | | | 50.76 % | $-8,250 | | | | | | News Article | History of Geewax Plus Partners Llc Ownership Of Nabi Biopharmaceuticals |
| 2009-11-04 | 2009-08-31 | N-CSR | Ssga Funds - Ssga Enhanced Small Cap Fund | Small-Cap Core | 2,258 | Sold Some | -742 | -24.73 % | $7,339 | $11,064 | $3,726 | 50.76 % | $-1,224 | | | | | | News Article | History of Ssga Funds - Ssga Enhanced Small Cap Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-11-04 | 2009-08-31 | N-CSR | Ssga Funds - Ssga Small Cap Fund | Small-Cap Core | | Sold All | -2,800 | -100 % | | | | 50.76 % | $-4,620 | | | | | | News Article | History of Ssga Funds - Ssga Small Cap Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-11-03 | 2009-09-30 | 13F-HR | Prudential Financial Inc | Institution | 25,695 | Added More | 4,800 | 22.97 % | $82,224 | $125,906 | $43,682 | 53.12 % | $8,160 | | | | | | News Article | History of Prudential Financial Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-10-30 | 2009-09-30 | 13F-HR | Oxford Asset Management | Institution | 12,174 | Sold Some | -31,333 | -72.01 % | $39,566 | $59,653 | $20,087 | 50.76 % | $-51,699 | | | | | | News Article | History of Oxford Asset Management Ownership Of Nabi Biopharmaceuticals |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock | Specialty & Misc | 4,041 | No Compare | | | $13,133 | $19,801 | $6,668 | 50.76 % | | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock Ownership Of Nabi Biopharmaceuticals |
| 2009-10-30 | 2009-08-31 | N-CSR | Vanguard World Fund - Vanguard Health Care Index Fund | Health/Biotech | 24,303 | New Holding | 24,303 | 100 % | $78,985 | $119,085 | $40,100 | 50.76 % | $40,100 | | | | | | News Article | History of Vanguard World Fund - Vanguard Health Care Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 1,728,173 | Sold Some | -15,400 | -0.88 % | $5,668,407 | $8,468,048 | $2,799,640 | 49.39 % | $-24,948 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Cornerstone Strategy Fund | Specialty & Misc | | Sold All | -2,800 | -100 % | | | | 49.39 % | $-4,536 | | | | | | News Article | History of Usaa Mutual Funds Trust - Cornerstone Strategy Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Small Cap Index Fund | Small-Cap Core | 41,679 | New Holding | 41,679 | 100 % | $136,707 | $204,227 | $67,520 | 49.39 % | $67,520 | | | | | | News Article | History of Valic Co I - Small Cap Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-10-28 | 2009-09-30 | 13F-HR | Carl Domino Inc | Institution | | Sold All | -15,457 | -100 % | | | | 53.60 % | $-26,431 | | | | | | News Article | History of Carl Domino Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 1,000 | New Holding | 1,000 | 100 % | $3,230 | $4,900 | $1,670 | 51.70 % | $1,670 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Group Ltd | Institution | 16,500 | No Change | 0 | 0 % | $54,780 | $80,850 | $26,070 | 47.59 % | $0 | | | | | | News Article | History of Blackrock Group Ltd Ownership Of Nabi Biopharmaceuticals |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | | Sold All | -16,100 | -100 % | | | | 47.59 % | $-25,438 | | | | | | News Article | History of Blackrock Inc Ownership Of Nabi Biopharmaceuticals |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 144,506 | Added More | 27,172 | 23.15 % | $479,760 | $708,079 | $228,319 | 47.59 % | $42,932 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Nabi Biopharmaceuticals |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 233,894 | Sold Some | -23,400 | -9.09 % | $785,884 | $1,146,081 | $360,197 | 45.83 % | $-36,036 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Nabi Biopharmaceuticals |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 110,274 | Added More | 17,868 | 19.33 % | $370,521 | $540,343 | $169,822 | 45.83 % | $27,517 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of Nabi Biopharmaceuticals |
| 2009-10-20 | 2009-09-30 | 13F-HR | Public Employees Retirement Association Of Colorado | Institution | 34,400 | No Change | 0 | 0 % | $120,056 | $168,560 | $48,504 | 40.40 % | $0 | | | | | | News Article | History of Public Employees Retirement Association Of Colorado Ownership Of Nabi Biopharmaceuticals |
| 2009-10-19 | 2009-09-30 | 13F-HR | Strs Ohio | Institution | 420,600 | Added More | 17,300 | 4.28 % | $1,509,954 | $2,060,940 | $550,986 | 36.49 % | $22,663 | | | | | | News Article | History of Strs Ohio Ownership Of Nabi Biopharmaceuticals |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 62,801 | No Change | 0 | 0 % | $229,224 | $307,725 | $78,501 | 34.24 % | $0 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Nabi Biopharmaceuticals |
| 2009-10-15 | 2008-06-30 | 13F-HR/A | Clarivest Asset Management Llc | Institution | 131,100 | New Holding | 131,100 | 100 % | $478,515 | $642,390 | $163,875 | 34.24 % | $163,875 | | | | | | News Article | History of Clarivest Asset Management Llc Ownership Of Nabi Biopharmaceuticals |
| 2009-10-15 | 2007-03-31 | 13F-HR/A | Northwestern Mutual Life Insurance Co | Institution | | Sold All | -1,625 | -100 % | | | | 34.24 % | $-2,031 | | | | | | News Article | History of Northwestern Mutual Life Insurance Co Ownership Of Nabi Biopharmaceuticals |
| 2009-10-14 | 2009-09-30 | 13F-HR | Intrust Bank Na | Institution | | Sold All | -21,806 | -100 % | | | | 33.15 % | $-26,603 | | | | | | News Article | History of Intrust Bank Na Ownership Of Nabi Biopharmaceuticals |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 86,653 | Added More | 350 | 0.40 % | $316,283 | $424,600 | $108,316 | 34.24 % | $438 | | | | | | News Article | History of Rhumbline Advisers Ownership Of Nabi Biopharmaceuticals |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 110,297 | No Change | 0 | 0 % | $397,069 | $540,455 | $143,386 | 36.11 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of Nabi Biopharmaceuticals |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio | No Data | 56,861 | No Change | 0 | 0 % | $204,700 | $278,619 | $73,919 | 36.11 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio Ownership Of Nabi Biopharmaceuticals |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio | No Data | 1,400 | No Change | 0 | 0 % | $5,040 | $6,860 | $1,820 | 36.11 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio Ownership Of Nabi Biopharmaceuticals |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Va International Value Portfolio | Multi-Cap Value | 1,000 | No Change | 0 | 0 % | $3,600 | $4,900 | $1,300 | 36.11 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Va International Value Portfolio Ownership Of Nabi Biopharmaceuticals |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Va Small Value Portfolio | Small-Cap Value | 138,689 | No Change | 0 | 0 % | $499,280 | $679,576 | $180,296 | 36.11 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Va Small Value Portfolio Ownership Of Nabi Biopharmaceuticals |
| 2009-09-29 | 2009-07-31 | N-Q | Jnl Investors Series Trust - Jackson Perspective Index 5 Fund | Specialty & Misc | 1,150 | No Change | 0 | 0 % | $4,140 | $5,635 | $1,495 | 36.11 % | $0 | | | | | | News Article | History of Jnl Investors Series Trust - Jackson Perspective Index 5 Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-09-29 | 2009-07-31 | N-Q | Russell Investment Co - International Fund | International Multi-Cap Core | | Sold All | -110,900 | -100 % | | | | 36.11 % | $-144,170 | | | | | | News Article | History of Russell Investment Co - International Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-09-29 | 2009-07-31 | N-Q | Vanguard Explorer Fund - Vanguard Explorer Fund | Small-Cap Growth | | Sold All | -95,300 | -100 % | | | | 36.11 % | $-123,890 | | | | | | News Article | History of Vanguard Explorer Fund - Vanguard Explorer Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-09-28 | 2009-07-31 | N-Q | Old Westbury Funds Inc - International Fund | International Multi-Cap Core | 9,600 | No Change | 0 | 0 % | $35,712 | $47,040 | $11,328 | 31.72 % | $0 | | | | | | News Article | History of Old Westbury Funds Inc - International Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust - Powershares Dynamic Small Cap Growth Portfolio | Small-Cap Growth | 872 | New Holding | 872 | 100 % | $3,244 | $4,273 | $1,029 | 31.72 % | $1,029 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust - Powershares Dynamic Small Cap Growth Portfolio Ownership Of Nabi Biopharmaceuticals |
| 2009-09-28 | 2009-07-31 | N-Q | Schwab Capital Trust - Schwab Health Care Fund | Health/Biotech | 100,000 | No Change | 0 | 0 % | $372,000 | $490,000 | $118,000 | 31.72 % | $0 | | | | | | News Article | History of Schwab Capital Trust - Schwab Health Care Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-09-24 | 2009-06-30 | 13F-HR/A | Credit Agricole S A | Institution | | Sold All | -400 | -100 % | | | | 40.80 % | $-568 | | | | | | News Article | History of Credit Agricole S A Ownership Of Nabi Biopharmaceuticals |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust - Rydex Inverse Russell 2000 Etf | Specialty & Misc | 1,100 | New Holding | 1,100 | 100 % | $3,740 | $5,390 | $1,650 | 44.11 % | $1,650 | | | | | | News Article | History of Rydex Etf Trust - Rydex Inverse Russell 2000 Etf Ownership Of Nabi Biopharmaceuticals |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 3,465,184 | Added More | 2,409 | 0.06 % | $11,469,759 | $16,979,402 | $5,509,643 | 48.03 % | $3,830 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Nabi Biopharmaceuticals |
| 2009-09-10 | 2009-06-30 | N-CSRS | Northern Lights Variable Trust - Jnf Equity Portfolio | Specialty & Misc | | Sold All | -3,400 | -100 % | | | | 45.83 % | $-5,236 | | | | | | News Article | History of Northern Lights Variable Trust - Jnf Equity Portfolio Ownership Of Nabi Biopharmaceuticals |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds - Banking Fund | Financial Services | 1,374 | Sold Some | -284 | -17.12 % | $4,438 | $6,733 | $2,295 | 51.70 % | $-474 | | | | | | News Article | History of Rydex Series Funds - Banking Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Biotechnology Fund | Health/Biotech | 664 | Added More | 250 | 60.38 % | $2,145 | $3,254 | $1,109 | 51.70 % | $418 | | | | | | News Article | History of Rydex Variable Trust - Biotechnology Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio | Small-Cap Growth | 21,400 | Added More | 16,500 | 336.73 % | $68,694 | $104,860 | $36,166 | 52.64 % | $27,885 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio Ownership Of Nabi Biopharmaceuticals |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Value Portfolio | Small-Cap Value | 18,200 | Sold Some | -37,400 | -67.26 % | $58,422 | $89,180 | $30,758 | 52.64 % | $-63,206 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Value Portfolio Ownership Of Nabi Biopharmaceuticals |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 54,900 | No Change | 0 | 0 % | $176,229 | $269,010 | $92,781 | 52.64 % | $0 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio Ownership Of Nabi Biopharmaceuticals |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Value Portfolio | Multi-Cap Value | 9,160 | New Holding | 9,160 | 100 % | $29,404 | $44,884 | $15,480 | 52.64 % | $15,480 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Value Portfolio Ownership Of Nabi Biopharmaceuticals |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | 67,687 | Added More | 1,230 | 1.85 % | $217,275 | $331,666 | $114,391 | 52.64 % | $2,079 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of Nabi Biopharmaceuticals |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Prime Money Market Fund | Specialty & Misc | 38 | New Holding | 38 | 100 % | $122 | $186 | $64 | 52.64 % | $64 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Prime Money Market Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust Ii - Jpmorgan Small Cap Value Fund | Small-Cap Value | 38 | Sold Some | -1 | -2.56 % | $122 | $186 | $64 | 52.64 % | $-2 | | | | | | News Article | History of Jpmorgan Trust Ii - Jpmorgan Small Cap Value Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 2,590 | Added More | 590 | 29.50 % | $8,314 | $12,691 | $4,377 | 52.64 % | $997 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Institutional Index Funds - Vanguard Institutional Index Fund | Specialty & Misc | 28,374 | New Holding | 28,374 | 100 % | $91,081 | $139,033 | $47,952 | 52.64 % | $47,952 | | | | | | News Article | History of Vanguard Institutional Index Funds - Vanguard Institutional Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Small-Cap Growth Index Portfolio | No Data | 685 | No Compare | | | | $3,357 | | - % | | | | | | | News Article | History of Pacific Select Fund - Pd Small-Cap Growth Index Portfolio Ownership Of Nabi Biopharmaceuticals |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Small-Cap Value Index Portfolio | No Data | 202 | No Compare | | | | $990 | | - % | | | | | | | News Article | History of Pacific Select Fund - Pd Small-Cap Value Index Portfolio Ownership Of Nabi Biopharmaceuticals |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Small-Cap Index Portfolio | No Data | 27,813 | New Holding | 27,813 | 100 % | | $136,284 | | - % | | | | | | | News Article | History of Pacific Select Fund - Small-Cap Index Portfolio Ownership Of Nabi Biopharmaceuticals |
| 2009-09-03 | 2009-06-30 | N-CSR | Streettracks Series Trust - Spdr Dividend Etf | Specialty & Misc | 1,247 | Added More | 206 | 19.78 % | | $6,110 | | - % | | | | | | | News Article | History of Streettracks Series Trust - Spdr Dividend Etf Ownership Of Nabi Biopharmaceuticals |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Amvescap Plc | Institution | 28,156 | Sold Some | -51,000 | -64.42 % | $83,905 | $137,964 | $54,060 | 64.42 % | $-97,920 | | | | | | News Article | History of Amvescap Plc Ownership Of Nabi Biopharmaceuticals |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Stock Index Fund | Specialty & Misc | 612 | No Change | 0 | 0 % | $1,867 | $2,999 | $1,132 | 60.65 % | $0 | | | | | | News Article | History of Tiaa Cref Life Fund - Stock Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | 655,236 | Sold Some | -31,626 | -4.60 % | $2,031,232 | $3,210,656 | $1,179,425 | 58.06 % | $-56,927 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Growth Index Fund | Multi-Cap Growth | 268,452 | Added More | 238,678 | 801.63 % | $832,201 | $1,315,415 | $483,214 | 58.06 % | $429,620 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Growth Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Index Fund | Specialty & Misc | 630,031 | Sold Some | -13,377 | -2.07 % | $1,953,096 | $3,087,152 | $1,134,056 | 58.06 % | $-24,079 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Value Index Fund | Multi-Cap Value | 116,658 | Sold Some | -258,054 | -68.86 % | $361,640 | $571,624 | $209,984 | 58.06 % | $-464,497 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Value Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 2,383 | Added More | 1,831 | 331.70 % | $7,387 | $11,677 | $4,289 | 58.06 % | $3,296 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Growth Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | 16,233 | Added More | 960 | 6.28 % | $50,322 | $79,542 | $29,219 | 58.06 % | $1,728 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Value Index Fund | Multi-Cap Value | 941 | Sold Some | -2,751 | -74.51 % | $2,917 | $4,611 | $1,694 | 58.06 % | $-4,952 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Value Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Microcap Index Fund | Specialty & Misc | 84,743 | Added More | 13,907 | 19.63 % | $262,703 | $415,241 | $152,537 | 58.06 % | $25,033 | | | | | | News Article | History of Ishares Trust - Ishares Russell Microcap Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 11,113 | Added More | 529 | 4.99 % | $34,450 | $54,454 | $20,003 | 58.06 % | $952 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Nabi Biopharmaceuticals |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Equity Index Fund | Specialty & Misc | 33,642 | Added More | 1,382 | 4.28 % | $106,982 | $164,846 | $57,864 | 54.08 % | $2,377 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Equity Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Growth Equity Fund | Multi-Cap Growth | | Sold All | -2,544 | -100 % | | | | 54.08 % | $-4,376 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Growth Equity Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | 406,658 | New Holding | 406,658 | 100 % | $1,293,172 | $1,992,624 | $699,452 | 54.08 % | $699,452 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Growth Index Fund | Large-Cap Growth | 259,213 | New Holding | 259,213 | 100 % | $824,297 | $1,270,144 | $445,846 | 54.08 % | $445,846 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Growth Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 653,863 | New Holding | 653,863 | 100 % | $2,079,284 | $3,203,929 | $1,124,644 | 54.08 % | $1,124,644 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Value Index Fund | Large-Cap Value | 144,029 | New Holding | 144,029 | 100 % | $458,012 | $705,742 | $247,730 | 54.08 % | $247,730 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Value Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 28,171 | No Change | 0 | 0 % | $89,584 | $138,038 | $48,454 | 54.08 % | $0 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 34,071 | Added More | 5,900 | 20.94 % | $108,346 | $166,948 | $58,602 | 54.08 % | $10,148 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Nabi Biopharmaceuticals |
| 2009-08-26 | 2009-06-30 | N-Q | Vanguard Quantitative Funds - Vanguard Structured Broad Market | Multi-Cap Core | | Sold All | -53,900 | -100 % | | | | 54.08 % | $-92,708 | | | | | | News Article | History of Vanguard Quantitative Funds - Vanguard Structured Broad Market Ownership Of Nabi Biopharmaceuticals |
RSS feed for NABI